"Slippery" is a very charitable way of describing
Post# of 148179
If Pourhassan believed in the company and Leronlimab as much as he claims, he would have presumably purchased some stock on the open market.
With a 50% raise, Pourhassan no longer has any excuse--not that he did before--for not purchasing stock.
How Pourhassan managed to finagle a 50% raise, and a total compensation package of $1.5M is astounding given how shareholders have suffered under his watch.
In the back of my mind I cannot help but wonder if Pourhassan might possibly be conning the investors to keep his compensation flowing.
Saltz, I, like you, tendered all of my warrants based upon Pourhassan's litany of good news at the time, little of which has come to fruition.
While I continue to believe in the science, I continue to distrust Pourhassan, and have serious concerns about his ability to lead this company to a successful conclusion.
LM